Lars Peter Fredell
🇸🇪Chief Executive Officer (CEO)/Managing Directory · 3 companies
Buys
23
Sells
0
Total bought
€113k
Total sold
€0
Activity (last 18 months)
05
06
07
08
09
10
11
12
01
02
03
04
05
06
07
08
09
10
buys sells
Buy vimab group ab
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
Transaction history
Under EU Market Abuse Regulation Article 19, insiders only disclose trades in their own employer's stock. Other personal investments aren't publicly reported — so a single-ticker history is normal, not a gap in our data.
| Date | Type | Company | Shares | Price | Value | Venue |
|---|---|---|---|---|---|---|
| 2025-10-02 1y ago | BUY | vimab group ab$VIMAB | 10,000 | €0.61 | €6k | NASDAQ STOCKHOLM AB |
| 2025-10-01 1y ago | BUY | vimab group ab$VIMAB | 5,000 | €0.61 | €3k | NASDAQ STOCKHOLM AB |
| 2025-09-30 1y ago | BUY | vimab group ab$VIMAB | 5,000 | €0.59 | €3k | NASDAQ STOCKHOLM AB |
| 2025-09-29 1y ago | BUY | vimab group ab$VIMAB | 7,000 | €0.59 | €4k | NASDAQ STOCKHOLM AB |
| 2025-07-22 1y ago | BUY | Vimab Group AB$VIMAB | 5,000 | €0.68 | €3k | NASDAQ STOCKHOLM AB |
| 2025-07-21 1y ago | BUY | Vimab Group AB$VIMAB | 15,320 | €0.68 | €10k | NASDAQ STOCKHOLM AB |
| 2025-03-26 1y ago | BUY | vimab group ab$VIMAB | 5,000 | €0.82 | €4k | NASDAQ STOCKHOLM AB |
| 2025-03-13 1y ago | BUY | VIMAB GROUP AB$VIMAB | 12,041 | €0.67 | €8k | NASDAQ STOCKHOLM AB |
| 2025-02-14 1y ago | BUY | vimab group ab$VIMAB | 9,769 | €0.85 | €8k | NASDAQ STOCKHOLM AB |
| 2023-10-09 3y ago | BUY | vimab group ab$VIMAB | 13,035 | €0.85 | €11k | NASDAQ STOCKHOLM AB |
| 2023-10-06 3y ago | BUY | vimab group ab$VIMAB | 1,700 | €0.78 | €1k | NASDAQ STOCKHOLM AB |
| 2023-10-05 3y ago | BUY | vimab group ab$VIMAB | 3,790 | €0.76 | €3k | NASDAQ STOCKHOLM AB |
| 2023-10-04 3y ago | BUY | vimab group ab$VIMAB | 8,201 | €0.71 | €6k | NASDAQ STOCKHOLM AB |
| 2023-10-03 3y ago | BUY | vimab group ab$VIMAB | 1,099 | €0.70 | €774 | NASDAQ STOCKHOLM AB |
| 2023-10-02 3y ago | BUY | vimab group ab$VIMAB | 7,180 | €0.64 | €5k | NASDAQ STOCKHOLM AB |
| 2023-09-29 3y ago | BUY | vimab group ab$VIMAB | 1,500 | €0.65 | €980 | NASDAQ STOCKHOLM AB |
| 2023-09-28 3y ago | BUY | vimab group ab$VIMAB | 2,811 | €0.66 | €2k | NASDAQ STOCKHOLM AB |
| 2023-09-27 3y ago | BUY | vimab group ab$VIMAB | 5,679 | €0.66 | €4k | NASDAQ STOCKHOLM AB |
| 2023-09-22 3y ago | BUY | vimab group ab$VIMAB | 6,876 | €0.65 | €4k | NASDAQ STOCKHOLM AB |
| 2023-09-21 3y ago | BUY | vimab group ab$VIMAB | 5,286 | €0.61 | €3k | NASDAQ STOCKHOLM AB |
| 2023-09-15 3y ago | BUY | vimab group ab$VIMAB | 7,896 | €0.64 | €5k | NASDAQ STOCKHOLM AB |
| 2023-09-13 3y ago | BUY | vimab group ab$VIMAB | 9,163 | €0.60 | €5k | NASDAQ STOCKHOLM AB |
| 2023-03-24 3y ago | BUY | vimab group ab$VIMAB | 10,000 | €1.13 | €11k | NASDAQ STOCKHOLM AB |